Literature DB >> 12874078

Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma.

Hernan E Gonzalez1, Manu Gujrati, Mitchell Frederick, Ying Henderson, Jayakumar Arumugam, Paul W Spring, Kenji Mitsudo, Hyung-Woo Kim, Gary L Clayman.   

Abstract

BACKGROUND: Current treatment modalities in squamous cell carcinoma of the head and neck have failed to improve survival. Advances in the discovery of novel biomarkers and targets for therapy are necessary.
DESIGN: Differential display and microarray analysis were used to identify differences in gene expression between squamous carcinoma and matched nonmalignant biopsy specimens. Differences in gene expression found in vivo were also tested in vitro by comparing primary cultured normal oral epithelium with head and neck squamous cell carcinoma (HNSCC) cell lines. Results were confirmed by relative reverse transcriptase-polymerase chain reaction and immunohistochemical analysis.
RESULTS: In tumors, microarray analysis showed down-regulation of calgranulin B (CAGB), CD24, lymphoepithelial Kazal-type-related inhibitor (LEKTI), zinc finger protein (ZNF-185), transglutaminase-3 (TGM3), and the ETS homologous factor (EHF). In addition, differential display revealed down-regulation of headpin. In contrast, periostin and the human homologue of the Drosophila white gene (ABCG1) were found to be up-regulated by microarray analysis and differential display, respectively. In HNSCC cell lines, LEKTI, ZNF-185, TGM3, headpin, and ABCG1 showed an expression pattern similar to that observed in tumor specimens. Periostin showed an opposite expression pattern in cell lines compared with that of tumor specimens. No consistent pattern of expression was found for CAGB, CD24, and EHF in cell lines. Immunohistochemical analysis revealed that the expression of headpin in nonmalignant mucosa was undetectable in tumors.
CONCLUSION: Using differential display and microarray analysis, we have identified and confirmed the differential expression of 9 genes in HNSCC. Work is in progress to determine the biological significance of these genes and their potential as biomarkers or targets for therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874078     DOI: 10.1001/archotol.129.7.754

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  35 in total

1.  Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma.

Authors:  Wei Liu; Zai-Cheng Yu; Wen-Feng Cao; Fang Ding; Zhi-Hua Liu
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

2.  Identification of epithelial auto-antigens associated with periodontal disease.

Authors:  P Ye; M Simonian; M A Nadkarni; A A Decarlo; C C Chapple; N Hunter
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

3.  Intracellular calprotectin (S100A8/A9) controls epithelial differentiation and caspase-mediated cleavage of EGFR in head and neck squamous cell carcinoma.

Authors:  Prokopios P Argyris; Zachary Slama; Chris Malz; Ioannis G Koutlas; Betty Pakzad; Ketan Patel; Deepak Kademani; Ali Khammanivong; Mark C Herzberg
Journal:  Oral Oncol       Date:  2019-06-04       Impact factor: 5.337

4.  Spectra of antinuclear antibodies in patients with squamous cell carcinoma of the lung and of the head and neck.

Authors:  Félix Fernández Madrid; Robert L Karvonen; John Ensley; Michael Kraut; José L Granda; Huda Alansari; Naimei Tang; John E Tomkiel
Journal:  Cancer Detect Prev       Date:  2005-01-28

Review 5.  Calprotectin and the Initiation and Progression of Head and Neck Cancer.

Authors:  P P Argyris; Z M Slama; K F Ross; A Khammanivong; M C Herzberg
Journal:  J Dent Res       Date:  2018-02-14       Impact factor: 6.116

6.  Gene expression profiling identifies genes predictive of oral squamous cell carcinoma.

Authors:  Chu Chen; Eduardo Méndez; John Houck; Wenhong Fan; Pawadee Lohavanichbutr; Dave Doody; Bevan Yueh; Neal D Futran; Melissa Upton; D Gregory Farwell; Stephen M Schwartz; Lue Ping Zhao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07-31       Impact factor: 4.254

7.  Periostin is up-regulated in high grade and high stage prostate cancer.

Authors:  Verena Tischler; Florian R Fritzsche; Peter J Wild; Carsten Stephan; Hans-Helge Seifert; Marc-Oliver Riener; Thomas Hermanns; Ashkan Mortezavi; Josefine Gerhardt; Peter Schraml; Klaus Jung; Holger Moch; Alex Soltermann; Glen Kristiansen
Journal:  BMC Cancer       Date:  2010-06-09       Impact factor: 4.430

8.  Zinc finger protein 185 is a liver metastasis-associated factor in colon cancer patients.

Authors:  Daisuke Furukawa; Tsuyoshi Chijiwa; Masahiro Matsuyama; Masaya Mukai; Ei-Ichi Matsuo; Osamu Nishimura; Kenji Kawai; Hiroshi Suemizu; Nobuyoshi Hiraoka; Toshio Nakagohri; Seiei Yasuda; Masato Nakamura
Journal:  Mol Clin Oncol       Date:  2014-05-29

9.  Molecular cloning and characterization of a novel mouse actin-binding protein Zfp185.

Authors:  Na Wang; Quanhui Zheng; Jin-San Zhang; Yong Zhao
Journal:  J Mol Histol       Date:  2008-02-01       Impact factor: 2.611

10.  Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse.

Authors:  Benjamin Lallemant; Alexandre Evrard; Christophe Combescure; Heliette Chapuis; Guillaume Chambon; Caroline Raynal; Christophe Reynaud; Omar Sabra; Dominique Joubert; Frédéric Hollande; Jean-Gabriel Lallemant; Serge Lumbroso; Jean-Paul Brouillet
Journal:  BMC Cancer       Date:  2009-10-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.